Anti-Platelets in Chronic Obstructive Pulmonary Disease

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 27, 2024

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2025

Conditions

COPDEmphysemaEmphysema or COPD

Interventions

COMBINATION_PRODUCT

dual anti-platelet therapy

DRUG

Placebo

Trial Locations (1)

Brigham and Women's Hospital, Boston

All Listed Sponsors

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Brigham and Women's Hospital

OTHER

NCT05567562 - Anti-Platelets in Chronic Obstructive Pulmonary Disease | Biotech Hunter | Biotech Hunter